Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a
Date
2015Author
Araz-Ersan, Bilge
Gül, Ahmet
Aydinoglu-Candan, Ozlem
Tugal-Tutkun, Ilknur
Badur, Selim
Metadata
Show full item recordAbstract
Recombinant human (rh) interferon alpha2a (IFN-alpha 2a) therapy is successfully used for the treatment of Beh double dagger et's disease (BD) uveitis refractory to conventional immunosuppressive treatment.
Collections
- Makale [92796]